← All organizations
Highest phase reached
Phase 1
First clinical trial
Mar 14, 2019Last known activity
Sep 23, 2021
Acquired by AbbVie on Mar 7, 2022
Timeline
2010s
- Jun 1, 2017
Syndesi— Founded
2020s
- Mar 7, 2022
AbbVie— Acquired By
Drugs by trial phase (1 distinct, 3 trials)
Phase 1 (1 own, 0 via acquisition)
Recent trials (4)
- NCT05199142Lead sponsorPhase 1Sep 23, 2021
- NCT05212116Lead sponsorPhase 1Sep 16, 2021
- NCT05212116Study chairPhase 1Sep 16, 2021
- NCT05486195CollaboratorPhase 1Mar 14, 2019
Details
- Founded
- Brussels, BE Jun 1, 2017
- Last known activity
- Sep 23, 2021